SpringerLink
Log in

Induction of Multilineage Markers in Human Myeloma Cells and Their Down-Regulation by Interleukin 6

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Human primary myeloma cells are well known to be heterogeneous with regard to morphology and surface phenotype. We confirmed the heterogeneous expression of such multilineage markers as CD33, CD7, CD56, CD4, and CD86 in primary myeloma cells from 20 patients with multiple myeloma and in 8 human myeloma cell lines. CD33 expression in the Liu01 cell line, a subclone of U266 cells, and in vitamin D3-treated ILKM3 cells, correlated with a monocytoid morphology featuring convoluted nuclei and with increased C/EBPα expression. CD56+ myeloma cells from some myeloma patients and the CD56+ (but not the CD56-) myeloma cell lines expressed neuronal cell markers, such as neuron-specific enolase and β-tubulin III. CD7 expression in Liu01 cells and forskolin-stimulated U266 cells coincided with the presence of large cytoplasmic granules, and these cells featured increased expression of perforin messenger RNA and significant natural killer cell activity. Interleukin 6 (IL-6), a growth factor for myeloma cells, down-regulated CD33, CD7, or CD56 expression in primary myeloma cells, as well as in Liu01 cells. Therefore, these data suggest that human myeloma cells are capable of inducing the expression of multilineage markers and that IL-6 can down-regulate such expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams B, Dorfler P, Aguzzi A, et al. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the develo** CNS, and adult testis. Genes Dev. 1992;6:1589–1607.

    Article  PubMed  CAS  Google Scholar 

  2. Neurath M, Stuber ER, Strober W. BSAP: a key regulator of B-cell development and differentiation. Immunol Today. 1995;16:564–568.

    Article  PubMed  CAS  Google Scholar 

  3. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol. 1992;12:2662–2672.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol. 2004;22:55–79.

    Article  PubMed  CAS  Google Scholar 

  5. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. 1993;81:2658–2663.

    PubMed  CAS  Google Scholar 

  6. Mahmoud MS, Huang N, Nobuyoshi M, Lisukov IA, Tanaka H, Kawano MM. Altered expression of Pax-5 gene in human myeloma cells. Blood. 1996;87:4311–4315.

    PubMed  CAS  Google Scholar 

  7. Walter C, Guenet J, Simon D, et al. Pax: a murine multigene family of paired box-containing genes. Genomics. 1991;11:424–434.

    Article  Google Scholar 

  8. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax-5. Nature. 1999;401:556–562.

    Article  PubMed  CAS  Google Scholar 

  9. Rolink AG, Nutt SL, Melchers F, Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature. 1999;401:603–606.

    Article  PubMed  CAS  Google Scholar 

  10. Graf T. Differentiation plasticity of hematopoietic cells. Blood. 2002;99:3089–3101.

    Article  PubMed  CAS  Google Scholar 

  11. Lin P, Mahdavy M, Zhan F, Katz RL, Shaughnessy JD. Expression of PAX5 in CD20-positive multiple myeloma assessed by immuno-histochemistry and oligonucleotide microarray. Mod Pathol. 2004;17:1217–1222.

    Article  PubMed  CAS  Google Scholar 

  12. Kawano MM, Huang N, Harada H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993;82:564–570.

    PubMed  CAS  Google Scholar 

  13. Li F, Tsuyama N, Ishikawa H, et al. A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma. Blood. 2005;105:3295–3302.

    Article  PubMed  CAS  Google Scholar 

  14. Liu S, Ishikawa H, Tsuyama N, et al. Increased susceptibility to apoptosis in CD45+ myeloma cells accompanied by the increased expression of VDAC-1. Oncogene. 2006:25:419–429.

    Article  PubMed  CAS  Google Scholar 

  15. Bodger MP, Hart DN. Molecular cloning and functional analysis of the CD33 promoter. Br J Haematol. 1998;102:986–995.

    Article  PubMed  CAS  Google Scholar 

  16. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hemato-poietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity. 2004;21:853–863.

    Article  PubMed  CAS  Google Scholar 

  17. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood. 1997;90:489–519.

    PubMed  CAS  Google Scholar 

  18. Liberg D, Smale ST, Merkenschlager M. Upstream of Ikalos. Trends Immunol. 2003;24:567–570.

    Article  CAS  PubMed  Google Scholar 

  19. Cao Z, Flanders K, Bertolette D, et al. Level of phosphor-Smad2/3 are sensors of the interplay between effects of TGF-β and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. Blood. 2003;101:498–507.

    Article  PubMed  CAS  Google Scholar 

  20. Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233–2238.

    Article  PubMed  CAS  Google Scholar 

  21. di Sant’ Agnese PA. Neuroendocrine differentiation in the precursors of prostate cancer. Eur Urol. 1996;30:185–190.

    Article  Google Scholar 

  22. Cox ME, Deeble PD, Lakhani S, Parsons SJ. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res. 1999;59:3821–3830.

    PubMed  CAS  Google Scholar 

  23. Deeble PD, Murphy DJ, Parson SJ, Cox E. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol. 2001;21:8471–8482.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988;332:83–85.

    Article  PubMed  CAS  Google Scholar 

  25. Klein B, Zhang X, Content J, et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by inter-leukin-6. Blood. 1989;73:517–526.

    PubMed  CAS  Google Scholar 

  26. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct. 2001;26:137–148.

    Article  PubMed  CAS  Google Scholar 

  27. Duperray C, Klein B, Durie BG, et al. Phenotypic analysis of human myeloma cell lines. Blood. 1989;73:566–572.

    PubMed  CAS  Google Scholar 

  28. Van Camp B, Durie BG, Spier C, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood. 1990;76:377–382.

    PubMed  Google Scholar 

  29. Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood. 2004;104:607–618.

    Article  PubMed  CAS  Google Scholar 

  30. Zhan F, Harden J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99:1745–1757.

    Article  PubMed  CAS  Google Scholar 

  31. Tarte K, Zhan F, De Vos J, Klein B, Shaughnessy J. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 2003;102:592–600.

    Article  PubMed  CAS  Google Scholar 

  32. Aprikyan AA, Liles WC, Rodger E, Jonas M, Chi EY, Dale DC. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood. 2001;87:147–153.

    Article  Google Scholar 

  33. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998;18:4301–4314.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Haddad R, Guardiola P, Izac B, et al. Molecular characterization of early T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood. 2004;104:3918–3926.

    Article  PubMed  CAS  Google Scholar 

  35. Citarella F, Felici A, Brouwer M. Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2). Blood. 1997;90:1501–1507.

    PubMed  CAS  Google Scholar 

  36. Foka P, Irvine SA, Kockar F, Ramji DP. Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-α gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. Nucleic Acids Res. 2003;31:6722–6732.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A. 2003;100(suppl 1):11842–11849.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111.

    Article  PubMed  CAS  Google Scholar 

  39. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116:639–648.

    Article  CAS  PubMed  Google Scholar 

  40. Michor F, Hughes TP, Iwasa Y, et al. Dynamics of chronic myeloid leukemia. Nature. 2005;435:1267–1270.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Cellular Signal Analysis, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, 755-8505, Ube, Japan

    Shangqin Liu, Ken-ichiro Otsuyama, Zi Ma, Saeid Abroun, Karim Shamsasenjan, Jakia Amin & Michio M. Kawano

  2. Hiroshima Red Cross Hospital, Hiroshima, Japan

    Hideki Asaoku

Authors
  1. Shangqin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ken-ichiro Otsuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zi Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saeid Abroun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karim Shamsasenjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jakia Amin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hideki Asaoku
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michio M. Kawano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michio M. Kawano.

About this article

Cite this article

Liu, S., Otsuyama, Ki., Ma, Z. et al. Induction of Multilineage Markers in Human Myeloma Cells and Their Down-Regulation by Interleukin 6. Int J Hematol 85, 49–58 (2007). https://doi.org/10.1532/IJH97.06132

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06132

Key words

Search

Navigation